Evidence map›Paper›PMID 42195253›Full record

Observational studyMedicina (Kaunas, Lithuania)2026

Prevalence of Homologous Recombination Deficiency and Treatment Patterns in Patients with Newly Diagnosed Advanced Ovarian Cancer in Bulgaria: A Real-World Cohort Study (VALIDATE).

Jeliazko Arabadjiev, Krasimir Nikolov, Marchela Koleva, Nikolay Shopov, Ivan Tonev, Rossitza Krasteva, Ivan Donev, Valeriy Yordanov, Velko Minchev, Assia Konsoulova

Abstract readObservational StudyMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Medicina (Kaunas, Lithuania), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jeliazko ArabadjievMedical Oncology Clinic, Acibadem City Clinic University Hospital Tokuda, 1407 Sofia, Bulgaria.ORCID 0000-0003-2440-2760
Krasimir NikolovMedical Oncology Department, Complex Oncology Center-Burgas, 8000 Burgas, Bulgaria.
Marchela KolevaMedical Oncology Department, MHAT "Sveta Sofia", 1618 Sofia, Bulgaria.
Nikolay ShopovMedical Oncology Department, MHAT Central Onco Hospital, 4000 Plovdiv, Bulgaria.
Ivan TonevMedical Oncology Department, Complex Oncology Center-Plovdiv, 4002 Plovdiv, Bulgaria.
Rossitza KrastevaMedical Oncology Department, Uni Hospital Oncology Center, MHAT Uni Hospital, 4500 Panagyurishte, Bulgaria.
Ivan DonevMedical Oncology Department, MHAT Women's Health Hospital Nadezhda, 1330 Sofia, Bulgaria.ORCID 0000-0003-3045-3775
Valeriy YordanovMedical Oncology Department, Complex Oncology Center-Ruse, 7002 Ruse, Bulgaria.
Velko MinchevMedical Oncology Department, UMHAT Sofiamed, 1797 Sofia, Bulgaria.
Assia KonsoulovaBulgarian Joint Cancer Network, Women for Oncology-Bulgaria, Medical Oncology Department, USHATO "Prof. Ivan Chernozemski", 1756 Sofia, Bulgaria.

Funding

AstraZeneca Bulgaria 201340239
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Homologous RecombinationOvarian NeoplasmsAdultAgedBulgariaCohort StudiesFemaleHumansMiddle AgedPrevalenceRetrospective Studiesadvanced ovarian cancerBRCABulgariagenomic instabilitygenomic testinghomologous recombination deficiency

Identifiers

PMID42195253
PMCPMC13208283

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.